Medical Devices

Good news, bad news for Cook stent business

June 10, 2013
J.K. Wall
While Bloomington-based medical-device maker won approval for new bile duct stent, it has recalled its hot-selling arterial stent from all global markets.
More

Lilly's $30.6M tax abatement request clears hurdle

April 18, 2013
 IBJ Staff
The pharmaceutical firm has $400 million in projects in the works for its facilities south of downtown. City officials have advanced its request for tax breaks to a public hearing and final consideration May 1.
More

Lilly seeks $30.6M in tax breaks on downtown projects

April 15, 2013
Mason King
Indianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to a new manufacturing plant and improvements to existing operations downtown.
More

Lilly to spend $180M doubling size of Indy plant

April 2, 2013
The new investment will bring the plant's total price tag to $320 million as the pharmaceutical giant seeks to increase production of insulin and related products.
More

Medical device maker moving to Noblesville, adding jobs

March 12, 2013
Fishers-based Nexxt Spine LLC, a manufacturer of spinal implants, is consolidating operations and moving its headquarters and manufacturing facility to Noblesville.
More

Zimmer highly exposed to health-reform risk

January 28, 2013
J.K. Wall
Shares of Zimmer Holdings Inc. have generated impressive returns of 23 percent in the past year and some 2013 product launches could juice those results even further. But the Warsaw-based maker of orthopedic implants is also the most-exposed company in its industry to two key elements of health care reform: the medical device tax and bundled payments.
More

Cook wins approval for new stent

November 19, 2012
J.K. Wall
Bloomington-based Cook Medical won approval for the first drug-coated stent for clogged leg arteries in the United States, which accounts for 40 percent of the soon-to-be $3 billion market.
More

Purdue researcher harbors high hopes for new ventureRestricted Content

November 3, 2012
Scott Olson
Pete Kissinger hopes Phlebotics will follow in the footsteps of another of his creations, Bioanalytical Systems Inc.
More

Lilly to spend $140M on new insulin cartridge plant

November 1, 2012
J.K. Wall
About 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But only “some” of that number will be new hires.
More

Outlook gloomy for device investments

October 29, 2012
J.K. Wall
The amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association and PricewaterhouseCoopers.
More

Growing ENT market attracts Cook

September 10, 2012
J.K. Wall
Bloomington-based Cook Medical announced a new division to capitalize on the growing market for minimally invasive procedures to fix problems in ears, noses and throats, as well as other maladies of the head and neck.
More

Medical startup plans 71 jobs, seeks incentives

June 21, 2012
The city of Indianapolis granted preliminary approval for an eight-year tax abatement to Arcamed Inc., which plans to purchase $1.4 million in equipment to design and manufacture titanium and case-tray systems for surgical instruments.
More

Biomet gives ortho industry hope

June 18, 2012
J.K. Wall
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
More

House swipes at health law with repeal of medical device tax

June 8, 2012
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the 2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.
More

FDA’s $6.4B drug review fee plan passes Senate

May 24, 2012
Bloomberg News
The U.S. Senate voted to let regulators collect on a $6.4 billion fee agreement struck with Indianapolis-based Eli Lilly and Co., Medtronic Inc. and other companies to fund reviews of new drugs and medical devices through 2017.
More

BioCrossroads has stoked state's life sciences industry, but challenges remainRestricted Content

February 11, 2012
J.K. Wall
In the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies, an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national reports on life sciences.
More

French breast-implant recall could sway U.S. device debate

January 19, 2012
Bloomberg News
U.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
More

City set to cancel tax abatement for medical device firm

January 18, 2012
Polymer Technology Systems said in 2007 that it would make a $3 million investment at its operation on Zionsville Road and create 110 jobs.
More

Glucose monitor deal helps Roche catch up

November 7, 2011
J.K. Wall
Roche Diagnostics will partner with a San Diego firm to incorporate its continuous glucose monitoring sensor with a wireless handheld device Roche is developing to help diabetics test their blood sugar and track their glucose levels throughout the day.
More

Ortho firms pull back on doc payments

October 31, 2011
J.K. Wall
The number of payments in excess of $1 million didn’t change substantially from year to year, but orthopedic companies sharply cut their fees to surgeons who received the smallest amounts.
More

Cook Medical gets FDA panel's backing for stent

October 13, 2011
Bloomberg News
The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg.
More

FDA: Cook Medical’s stent met efficacy, safety goals

October 11, 2011
Bloomberg News
Peripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global revenue last year and may earn $5.6 billion in 2014.
More

Incentives flow to tech firm Positron, despite red inkRestricted Content

September 29, 2011
Chris O'Malley
The molecular-imaging company is trying to transition its business model and get beyond a going-concern warning.
More

Gloomy outlook for medical device makers

September 12, 2011
J.K. Wall
The next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.
More

Zimmer playing hardball with plaintiffs' lawyers

August 8, 2011
Bloomberg News
The Warsaw-based company has sued seven law firms this year and sent warning letters to at least three more, saying their ads and Internet postings distorted the safety record of its $1.8 billion-a-year knee business.
More
Page  1 2 3 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Thank you for pointing out the absurdity of having The Naked Cowboy at Zoobilation. For the life of me, I don’t know why anyone would want a picture with that guy, but there were plenty of folks lined up to get a shot with him. The event could have used more restrooms out on the bridge, more photo booths and vendors offering something besides meat. There were a few more veg-friendly options this year than last, but it has a long way to go.

  2. Went to Zoobilation Friday night and had a great time. The weather was super nice and the food was very good, for the most part. Lots of sliders this year at many different tents. The slider from Alexander's was inedible, all four in my group ended up tossing it after one bite. Some tents were out of food by 8:30 and one bar area was out of cups at 8:30, not sure how that can happen. Great event in Indy and I look forward to it each year.

  3. Many of the small community hospitals are now owned by the "cash-strapped" Indy biggies, with more coming. The doctor-practise buying has been done precisely to sidestep tiered payments for out-of-hospital procedures. These are no better done, or safer, because someone administers a pain shot or snaps an x-ray in a doctor's office. And the non-payment issue is resolved next year when we all have insurance, even though many still think paying private insurers an extra 10-20% is what makes our system "world-class".

  4. I'd love to see this rendering put into the context of the surrounding neighborhood/area to get a better feel for the surrounding scale. However, just by the looks of it, it appears to be an excellent project. I'm pretty sure that if Scott Olson had said nothing regarding Chicago or Wrigleyville, Mr. "Horrible" would have found nothing bad to say. I'd love to know how Indy is becoming "Chicagofied"...

  5. Truly great and funny play. Vocalists were Broadway caliber and stage settings ideal for small stage. Would go again!

ADVERTISEMENT